Paid Clinical Trials in Maine

Maine has 206 paid clinical trials enrolling now across cities including Scarborough, Portland and South Portland. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

189 clinical trials

Get a weekly email when new trials open in Scarborough, ME.

Supraglottic Airway for Resuscitation Trial

for Neonatal Resuscitation

Sites in Portland, Brunswick +28 more locations

Sponsor: Children's Hospital of Philadelphia

Sex: All·Age: 0 Days+

Code: NCT07150923·Recruiting·Listed Sep 2025

Apply to this trial

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

for Community-acquired Pneumonia

Sites in Portland +4 more locations

Sponsor: University of Manitoba

Sex: All·Age: 18+

Code: NCT05848713·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for Castration Levels of Testosterone

Sites in Scarborough, Portland +292 more locations

Sponsor: SWOG Cancer Research Network

Sex: Male·Age: 18+

Code: NCT03678025·Phase 3·Recruiting·Listed Sep 2018

Apply to this trial

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

for Atrial Fibrillation

Sites in Portland +34 more locations

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18+

Code: NCT04045665·Phase 3·Recruiting·Listed Aug 2019

Apply to this trial

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

for Chronic Lymphocytic Leukemia

Sites in Scarborough +3 more locations

Sponsor: Inhye Ahn

Sex: All·Age: 18+

Code: NCT06333262·Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

for Chronic Lymphocytic Leukemia (CLL)

Drug: Venetoclax

Sites in Scarborough +3 more locations

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT05168930·Phase 2·Recruiting·Listed Dec 2021

Apply to this trial

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for Advanced Pancreatic Carcinoma

Sites in Bar Harbor +108 more locations

Sponsor: Sameek Roychowdhury

Sex: All·Age: 18+

Code: NCT06906562·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

AWARE: Management of ADHD in Autism Spectrum Disorder

for ADHD

Sites in Portland +9 more locations

Sponsor: Daniel Coury

Sex: All·Age: 4 - 17

Code: NCT05916339·Phase 4·Recruiting·Listed Jun 2023

Apply to this trial

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

for End Stage Renal Disease

Sites in Portland +5 more locations

Sponsor: Johns Hopkins University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT03803423·Recruiting·Listed Jan 2019

Apply to this trial

Supporting Health in Veterans With Heart Failure

for Heart Failure

Sites in Togus +3 more locations

Sponsor: Florida State University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05839067·Recruiting·Listed May 2023

Apply to this trial

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for Hodgkin Lymphoma in Remission

Sites in Scarborough +55 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: All ages

Code: NCT01790152·Recruiting·Listed Feb 2013

Apply to this trial

Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)

for Cardiac Arrest

1 location in Portland

Sponsor: MaineHealth

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT02664831·Recruiting·Listed Jan 2016

Apply to this trial

Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS)

for Non-Traumatic Subarachnoid Hemorrhage

1 location in Portland

Sponsor: Madeleine Puissant

Sex: All·Age: 18+

Code: NCT06569212·Phase 4·Recruiting·Listed Aug 2024

Apply to this trial

Studies of Neuregulin/ERBB Signaling in Human Heart

for Heart Disease

1 location in Portland

Sponsor: Douglas B. Sawyer

Sex: All·Age: 18+

Code: NCT02820233·Recruiting·Listed Jun 2016

Apply to this trial

Cardiogenic Shock Working Group Registry

for Cardiogenic Shock

Sites in Portland +15 more locations

Sponsor: Tufts Medical Center

Sex: All·Age: 18+

Code: NCT04682483·Recruiting·Listed Dec 2020

Apply to this trial

Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting

for Burns Degree Third

Sites in Portland +3 more locations

Sponsor: XenoTherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06223269·Phase 3·Recruiting·Listed Jan 2024

Apply to this trial

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

for Disorder

Sites in Portland +2 more locations

Sponsor: Unity Health Toronto

Sex: All·Age: 18 - 65

Code: NCT04754022·Recruiting·Listed Feb 2021

Apply to this trial

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for Rhabdomyosarcoma

Sites in Scarborough, Portland +83 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for Non-small Cell Lung Cancer (NSCLC)

Sites in South Portland +47 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07291037·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

for Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Sites in Bangor +41 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 40 - 75

Code: NCT07177339·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Drug: AZD0780

Sites in Scarborough, Bangor +308 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Scarborough, Augusta +327 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for Non-squamous Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in South Portland +60 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06627647·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Scarborough +64 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for Endometrial Cancer

Sites in Scarborough +66 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for Acute Coronary Syndrome

Sites in Bangor +147 more locations

Sponsor: DalCor Pharmaceuticals

Sex: All·Age: 45+

Code: NCT05918861·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

Sites in Portland +29 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Sites in Bangor +54 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 40 - 80

Code: NCT06961214·Phase 3·Recruiting·Listed May 2025

Apply to this trial